Kite Pharma to Present at November 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq: KITE) today announced that management will present at three investor conferences in November:

• Credit Suisse 25th Annual Healthcare Conference

• Date: Monday, November 7, 2016
• Time: 2:30pm Mountain Time
• Location: Phoenix, AZ

• Jefferies London Healthcare Conference

• Date: Wednesday, November 16, 2016
• Time: 10:00am Greenwich Mean Time
• Location: London, UK

• Stifel 2016 Healthcare Conference

• Date: Wednesday, November 16, 2016
• Time: 1:30 PM Eastern Time
• Location: New York, NY

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005154/en/

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
[email protected]
or
Greg Mann
VP, Investor Relations
[email protected]

Source: Kite Pharma, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• East Oak Introduces The Pitmate™ Tabletop 20-In Electric Smoker: Real Wood-Smoked Flavor For Every Outdoor Space
• Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Fo
• Hennessy Capital Investment Corp. VII and ONE Nuclear Energy to Host Investor Update Call